Pathoquest_logo
  • About Us
    • Why PathoQuest
    • Leadership Team
    • Strategic Partnerships
    • Client Testimonials
    • Careers
  • Modalities
    • mAbs and Recombinant Proteins
    • Viral Vectors
    • Cell Therapies
    • Vaccines
    • RNA Therapies
    • Cultivated Meat
  • Services
    • Adventitious Virus Testing
    • In Vivo Replacement
    • Cell Line Characterization
    • Identity Confirmation
    • HLA Genotyping
    • Integration Site Analysis
    • Raw Material Testing
  • iDTECT® Platform
  • 3Rs
  • Quality & Regulatory
    • Quality
    • Regulatory
  • Resources
    • Publications
    • Brochures and Posters
    • Webinars and Talks
    • Our One-Minute Series on NGS
  • News
  • Contact

PathoQuest Appoints Colette Côté as Chief Portfolio Officer and General Manager of the Company’s U.S. Subsidiary

by pathoquest | Mar 13, 2021 | News

PathoQuest Appoints Colette Côté as Chief Portfolio Officer and General Manager of the Company’s U.S. Subsidiary WAYNE, PA, and PARIS, FRANCE – March 18, 2021 – PathoQuest, a pioneer in the development and application of novel Next Generation Sequencing (NGS)-based...

PathoQuest Appoints Guillaume Deplaine, Ph.D., as Head of Operations

by pathoquest | Jan 24, 2021 | News

PathoQuest Appoints Guillaume Deplaine, Ph.D., as Head of Operations Dr. Guillaume Deplaine has 10 years of experience in the Biotechnology industry. Prior to joining PathoQuest, Dr. Deplaine was the Quality Control and Analytical Development Head at CELLforCURE a...
Next Entries »

Home » News » Page 6

T: +33 (0)1 70 82 17 90
T: +1 484 212 9360

Copyright © 2026 – PathoQuest | Cookies Policy | Privacy Policy

T: +33 (0)1 70 82 17 90
T: +1 484 212 9360

Copyright © 2026 – PathoQuest | Cookies Policy | Privacy Policy

Cleantalk Pixel
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

Explore our full library of scientific resources

Access our latest thinking

Name(Required)
By submitting this form, PathoQuest will use the personal data you provide to handle your request. Read our Privacy Notice for more information.(Required)